BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Onyvax Limited 

P.O. Box 17717
St George's Hospital Medical School
Cranmer Terrace  London  SW17 0WG  United Kingdom
Phone: 44-181-682-9494 Fax: +44-181-682-9495


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Vaccines





 Company News
Onyvax Limited Identifies a Biomarker Profile That Could be Predictive of Response to Cancer Vaccines 11/11/2008 4:34:43 PM
Onyvax Limited European Phase IIB Clinical Trial Completes Enrolment 3/17/2008 11:59:28 AM
Onyvax Limited Funding Shot for Cell-Based Vaccines 1/14/2008 10:41:45 AM
Onyvax Limited Release: Phase IIb Clinical Trial Of Onyvax-P In Early Stage Prostate Cancer Initiated In United States 9/28/2007 11:29:37 AM
Onyvax Limited Raises £8 Million To Advance Development Of Prostate Cancer Vaccine 5/8/2006 4:55:58 PM
Eden Biodesign And Onyvax Limited Announce Biomanufacturing Contract 4/6/2006 1:54:53 PM
Onyvax Limited Release: University of Michigan Researchers Zero-In On CD55 3/27/2006 2:18:12 PM
Onyvax Limited Release: Onyvax-105 Cancer Vaccine Shows Encouraging Clinical Results In Osteosarcoma Patients After Intensive Chemotherapy10/19/2005 5:13:13 PM
Asterand, Inc. Announces New Cell Lines To Advance Prostate Cancer Research10/19/2005 5:10:01 PM
Onyvax Limited Publishes Results Of Phase II Prostate Cancer Vaccine Showing Significant Steps Towards Delaying Disease Progression10/19/2005 5:09:13 PM